ATE421951T1 - Gabusectin-derivate, verfahren zur deren herstellung und deren verwendung - Google Patents

Gabusectin-derivate, verfahren zur deren herstellung und deren verwendung

Info

Publication number
ATE421951T1
ATE421951T1 AT02803357T AT02803357T ATE421951T1 AT E421951 T1 ATE421951 T1 AT E421951T1 AT 02803357 T AT02803357 T AT 02803357T AT 02803357 T AT02803357 T AT 02803357T AT E421951 T1 ATE421951 T1 AT E421951T1
Authority
AT
Austria
Prior art keywords
derivatives
gabusectin
alkenyl
alkyl
optionally substituted
Prior art date
Application number
AT02803357T
Other languages
German (de)
English (en)
Inventor
Matthias Schiell
Martin Knauf
Luigi Toti
Astrid Markus-Erb
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE421951T1 publication Critical patent/ATE421951T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02803357T 2001-11-21 2002-11-07 Gabusectin-derivate, verfahren zur deren herstellung und deren verwendung ATE421951T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10156906A DE10156906A1 (de) 2001-11-21 2001-11-21 Gabusectin-Derivate, Verfahren zu deren Herstellung und deren Verwendung

Publications (1)

Publication Number Publication Date
ATE421951T1 true ATE421951T1 (de) 2009-02-15

Family

ID=7706333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02803357T ATE421951T1 (de) 2001-11-21 2002-11-07 Gabusectin-derivate, verfahren zur deren herstellung und deren verwendung

Country Status (10)

Country Link
EP (1) EP1448522B1 (xx)
JP (1) JP2006501132A (xx)
AT (1) ATE421951T1 (xx)
AU (1) AU2002366191B2 (xx)
CA (1) CA2467251A1 (xx)
DE (2) DE10156906A1 (xx)
IL (1) IL162069A0 (xx)
MX (1) MXPA04004537A (xx)
PE (1) PE20030538A1 (xx)
WO (1) WO2003043984A1 (xx)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476062B2 (en) * 2000-03-30 2002-11-05 Schering Corporation Chemokine receptor antagonists
DE10060810A1 (de) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Coniosetin und Derivate davon, Verfahren zur Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
DE10156906A1 (de) 2003-05-28
PE20030538A1 (es) 2003-08-01
EP1448522B1 (de) 2009-01-28
CA2467251A1 (en) 2003-05-30
AU2002366191B2 (en) 2008-01-31
IL162069A0 (en) 2005-11-20
WO2003043984A1 (de) 2003-05-30
AU2002366191A1 (en) 2003-06-10
EP1448522A1 (de) 2004-08-25
DE50213257D1 (de) 2009-03-19
JP2006501132A (ja) 2006-01-12
MXPA04004537A (es) 2004-08-11

Similar Documents

Publication Publication Date Title
NL350075I2 (xx)
PL342573A1 (en) Cyclic amine compounds
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
WO2004016578A8 (en) Arylethanolamine beta2-adrenoreceptor agonist compounds
MXPA04003007A (es) Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades.
TW200519088A (en) Aryl or heteroaryl amide compounds
GEP20074148B (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
YU55602A (sh) Amino derivati dihidro-1,3,5-triazina i njihova terapeutska primena
MXPA04001685A (es) Derivados de sulfonilamino empleados como herbicida.
TW200740800A (en) Oxazolidinone compounds, and compositions and methods related thereto
DE59914814D1 (de) Heterozyklische substituierte amide, deren herstellung und anwendung
TW200510317A (en) Caspase inhibitors and uses thereof
MXPA06003253A (es) Derivados de acido acetico substituidos.
IL166439A0 (en) Endiandric acid derivatives as c-maf inhibitors for using against asthma
MXPA04002495A (es) Compuestos de imidazopiridin como moduladores del receptor 5-ht4.
PT992509E (pt) Novos derivados macrolidos
MXPA04006041A (es) Antivirales de piridoquinoxalina.
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
ATE231160T1 (de) Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
RS44004A (xx) Postupak dobijanja supstituisanih bicikličnih derivata za lečenje abnormalnog rasta ćelija
ATE421951T1 (de) Gabusectin-derivate, verfahren zur deren herstellung und deren verwendung
MXPA04005151A (es) Compuestos terapeuticos.
ATE524449T1 (de) Verfahren zur herstellung von cis-8b- methyldecahydro-2a,4a,6a,8a- tetraazacyclopentaäfgüacenaphthylen, cis- decahydro-2a,4a,6a,8a- tetraazacyclopentaäfgüacenaphthylen, cyclen und funktionalisierten cyclenen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee